Different patterns of fibrinolytic abnormalities and lipid profile in hypothyroid and hyperthyroid patients

Different patterns of fibrinolytic abnormalities and lipid profile in hypothyroid and hyperthyroid patients

Altered fibrinolytic parameters and serum lipid profile are strongly related to thyroid dysfunction. To investigate the patterns of the fibrinolytic abnormalities and serum lipid profile in the hypo- and hyperthyroid patients. We also took an aim at studying the relationships between free T4 levels...

Full description

Saved in:
Bibliographic Details
Published in:Comparative clinical pathology Vol. 23; no. 2; pp. 407 - 413
Main Authors: Elgammal, Sahar A., El-Sherif, Wafaa T., Abdou, Madleen A., Afifi, Ola A., Alkorn, Ebtesam F., Galal, Sherif H., Kamal, Taghreed M., Saied, Ghada M., Soliman, Hamed A.
Format: Journal Article
Language:English
Published: London Springer London 01-03-2014
Springer Nature B.V
Subjects:
Hematology
Medicine
Medicine & Public Health
Oncology
Original Article
Pathology
D-dimer
Thyroid dysfunction
PAI-1
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Altered fibrinolytic parameters and serum lipid profile are strongly related to thyroid dysfunction. To investigate the patterns of the fibrinolytic abnormalities and serum lipid profile in the hypo- and hyperthyroid patients. We also took an aim at studying the relationships between free T4 levels (FT4) and these parameters. Hyperthyroid ( n  = 30), hypothyroid ( n  = 20) patients and euthyroid control subjects ( n  = 30) were evaluated for several fibrinolytic parameters including plasma plasminogen activator inhibitor-1 (PAI-1) and D-dimer (D-D). Serum lipid profile and lipoprotein(a) (Lp(a)) were also measured. We found different patterns of fibrinolytic abnormalities and lipid profile in hypo- and hyperthyroid patients. The hypothyroid patients had low plasma PAI-1 levels and high D-D values as compared to hyperthyroid patients ( p  < 0.001) and euthyroid control subjects ( p  < 0.05 and 0.001, respectively). In sharp contrast, the hyperthyroid patients had high plasma PAI-1 levels ( p  < 0.001) but without concomitant change in plasma D-D values, as compared to the euthyroid control subjects. Hypothyroidism was associated with high total cholesterol, triglycerides, LDL-C and Lp(a) levels and low HDL-C levels as compared to both hyperthyroid and euthyroid states ( p  < 0.001). FT4 levels were correlated positively with HDL-C but negatively with total cholesterol, triglycerides, LDL-C and Lp(a) levels in both hypo- and hyperthyroid patients. Also FT4 levels were correlated positively with PAI-1 but negatively with D-D in both hypo- and hyperthyroid patients ( p  < 0.02, 0.01, 0.001 and 0.03 respectively). We found hyperfibrinolytic, and hypofibrinolytic patterns in hypothyroid, hyperthyroid patients, respectively. The hypothyroid patients had atherogenic lipid profile. These variations indicate possible pathophysiologic roles for thyroid hormones in the regulation of the fibrinolytic system and lipid profile. Mechanisms of these variations are open for future investigations.
ISSN:1618-5641
1618-565X
DOI:10.1007/s00580-012-1633-0